High-efficiency biolistic transformation of Chlamydomonas mitochondria can be used to insert mutations in complex I genes.
Mitochondrial transformation of Chlamydomonas reinhardtii has been optimized by using a particle-gun device and cloned mitochondrial DNA or PCR fragments. A respiratory-deficient strain lacking a 1.2-kb mitochondrial DNA region including the left telomere and part of the cob gene could be rescued as well as a double-frameshift mutant in the mitochondrial cox1 and nd1 genes. High transformation efficiency has been achieved (100-250 transformants per microgram of DNA), the best results being obtained with linearized plasmid DNA. Molecular analysis of the transformants suggests that the right telomere sequence can be copied to reconstruct the left telomere by recombination. In addition, both nondeleterious and deleterious mutations could be introduced. Myxothiazol-resistant transformants have been created by introducing a nucleotide substitution into the cob gene. Similarly, an in-frame deletion of 23 codons has been created in the nd4 mitochondrial gene of both the deleted and frameshift recipient strains. These 23 codons are believed to encode the first transmembrane segment of the ND4 protein. This Deltand4 mutation causes a misassembly of complex I, with the accumulation of a subcomplex that is 250-kDa smaller than the wild-type complex I. The availability of efficient mitochondrial transformation in Chlamydomonas provides an invaluable tool for the study of mitochondrial biogenesis and, more specifically, for site-directed mutagenesis of mitochondrially encoded subunits of complex I, of special interest because the yeast Saccharomyces cerevisiae, whose mitochondrial genome can be manipulated virtually at will, is lacking complex I.
Génétique des Microorganismes, Département des Sciences de la Vie, Institut de Botanique B22, Université de Liège, B-4000 Liège, Belgium. c.remacle@ulg.ac.be
Claire
C
Remacle
Pierre
P
Cardol
Nadine
N
Coosemans
Mauricette
M
Gaisne
Nathalie
N
Bonnefoy
D000818:Animals; D019470:Biolistics / Q000379:methods*; D002696:Chlamydomonas / Q000187:drug effects / Q000235:genetics*; D004272:DNA, Mitochondrial / Q000235:genetics; D004351:Drug Resistance / Q000235:genetics; D042967:Electron Transport Complex I / Q000235:genetics*; D050259:Genes, Mitochondrial; D017125:Genes, Protozoan; D008689:Methacrylates / Q000494:pharmacology; D008928:Mitochondria / Q000235:genetics*; D016297:Mutagenesis, Site-Directed / Q000379:methods*; D009154:Mutation; D017384:Sequence Deletion; D016615:Telomere / Q000235:genetics; D013844:Thiazoles / Q000494:pharmacology; D014170:Transformation, Genetic
D004272:DNA, Mitochondrial; D008689:Methacrylates; D013844:Thiazoles; C030517:myxothiazol; D042967:Electron Transport Complex I